2021
Drip-and-ship versus mothership for endovascular treatment of acute stroke: A comparative effectiveness analysis
Wu X, Wira C, Matouk C, Forman H, Gandhi D, Sanelli P, Schindler J, Malhotra A. Drip-and-ship versus mothership for endovascular treatment of acute stroke: A comparative effectiveness analysis. International Journal Of Stroke 2021, 17: 315-322. PMID: 33759645, DOI: 10.1177/17474930211008701.Peer-Reviewed Original ResearchMeSH KeywordsBrain IschemiaHumansPatient TransferStrokeThrombectomyThrombolytic TherapyTime-to-TreatmentTreatment OutcomeTriageConceptsComprehensive stroke centerPrimary stroke centerAcute stroke patientsNearest comprehensive stroke centerAcute strokeMothership strategyStroke centersStroke patientsPlace of onsetHealth benefitsMarkov decision-analytic modelComparative effectiveness analysisRecent medical literatureMultiple sensitivity analysesDecision analytic modelMothership modelPrimary outcomeEndovascular treatmentPrehospital triageSudden onsetPatientsMedical literatureStrokeShip strategyTarget population
2020
Endovascular Contact Aspiration versus Stent Retriever for Revascularization in Patients with Acute Ischemic Stroke and Large Vessel Occlusion: A Cost-Minimization Analysis
Malhotra A, Boltyenkov A, Wu X, Matouk CC, Forman HP, Gandhi D, Sanelli P. Endovascular Contact Aspiration versus Stent Retriever for Revascularization in Patients with Acute Ischemic Stroke and Large Vessel Occlusion: A Cost-Minimization Analysis. World Neurosurgery 2020, 139: e23-e31. PMID: 32105871, DOI: 10.1016/j.wneu.2020.02.078.Peer-Reviewed Original ResearchClinical effectiveness and cost-effectiveness of teledermatology: Where are we now, and what are the barriers to adoption?
Wang RH, Barbieri JS, Nguyen HP, Stavert R, Forman HP, Bolognia JL, Kovarik CL, Dermatology F. Clinical effectiveness and cost-effectiveness of teledermatology: Where are we now, and what are the barriers to adoption? Journal Of The American Academy Of Dermatology 2020, 83: 299-307. PMID: 32035106, PMCID: PMC7302990, DOI: 10.1016/j.jaad.2020.01.065.Peer-Reviewed Original ResearchConceptsPatient careHigh-quality dermatologic carePractice-level barriersClinical efficacyClinical effectivenessCare settingsDermatologic careCare deliveryMedicaid ServicesTeledermatology servicesTeledermatology implementationTeledermatologyCareTelemedicine reimbursementDermatologistsPotential implications
2019
Comparative Effectiveness of Endovascular Thrombectomy in Elderly Stroke Patients
Malhotra A, Wu X, Payabvash S, Matouk CC, Forman HP, Gandhi D, Sanelli P, Schindler J. Comparative Effectiveness of Endovascular Thrombectomy in Elderly Stroke Patients. Stroke 2019, 50: 963-969. PMID: 30908156, DOI: 10.1161/strokeaha.119.025031.Peer-Reviewed Original ResearchMeSH KeywordsAged, 80 and overBrain IschemiaFemaleFibrinolytic AgentsHumansMaleStrokeThrombectomyTissue Plasminogen ActivatorTreatment OutcomeConceptsQuality-adjusted life yearsIntravenous thrombolysisEndovascular thrombectomyLarge vessel occlusionAge 80 yearsEVT strategyVessel occlusionModified Rankin Scale scorePoststroke functional outcomeAcute ischemic strokeRankin Scale scoreElderly stroke patientsMarkov decision-analytic modelYears of ageDecision analytic modelMultiple sensitivity analysesPurpose- StrokeAcute strokeBaseline disabilityElderly patientsIschemic strokeStroke patientsFunctional outcomeHealthy patientsAdvanced age
1994
CT screening for comorbid disease in patients with prostatic carcinoma: is it cost-effective?
Forman H, Heiken J, Brink J, Glazer H, Fox L, McClennan B. CT screening for comorbid disease in patients with prostatic carcinoma: is it cost-effective? American Journal Of Roentgenology 1994, 162: 1125-8; discussion 1129-30. PMID: 8165996, DOI: 10.2214/ajr.162.5.8165996.Peer-Reviewed Original ResearchConceptsComorbid diseasesProstatic carcinomaCT findingsFalse-positive CT findingsTime of diagnosisPopulation of patientsLack of efficacyScreening CT scanConsecutive patientsPreoperative evaluationProstatic surgeryMedical recordsClinical impactCT scanRadiation therapyPatientsCarcinomaFurther evaluationDiseaseCTMedicare reimbursementSurgeryTreatmentFindingsTherapy